Adial Pharmaceuticals, Inc. Equity Method Investments
Adial Pharmaceuticals, Inc. (ADIL) had Equity Method Investments of $241.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:EquityMethodInvestments · last filed 2026-08-14
- 2026-06-30: Equity Method Investments $241.00K.
- 2026-03-31: Equity Method Investments $421.73K.
- 2025-12-31: Equity Method Investments $490.00K; Equity Method Investments as first filed $489.70K.
- 2025-09-30: Equity Method Investments $643.09K.
| Period end | Equity Method Investments | Equity Method Investments as first filed |
|---|---|---|
| 2026-06-30 | $241.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $421.73K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $490.00K 10-Q · filed 2026-08-14 | $489.70K 10-K · filed 2026-03-05 |
| 2025-09-30 | $643.09K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $720.01K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $818.74K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $981.83K 10-K · filed 2026-03-05 | |
| 2024-09-30 | $1.09M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $1.12M 10-Q · filed 2024-08-13 | |
| 2023-12-31 | $1.53M 10-K · filed 2025-03-04 | |
| 2023-09-30 | $1.73M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $1.73M 10-Q/A · filed 2023-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |